Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

INTRODUCTION: Ascertainment of the pattern and temporal change of biomarkers in preclinical (asymptomatic) sporadic Alzheimer's disease (AD) will increase knowledge about early pathogenesis and facilitate interventional therapeutic trials. METHODS: In this prospective longitudinal study, repeat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Alzheimers Dement (Amst)
Auteurs principaux: Stomrud, Erik, Minthon, Lennart, Zetterberg, Henrik, Blennow, Kaj, Hansson, Oskar
Format: Artigo
Langue:Inglês
Publié: Elsevier 2015
Sujets:
CSF Biomarkers
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879483/
https://ncbi.nlm.nih.gov/pubmed/27239521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.09.002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires